Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies

NCT02485717 is registered in ClinicalTrials.gov with ParaPRO LLC as lead sponsor.

NCT NCT02485717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02485717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies
Lead sponsor
ParaPRO LLC
Phase
Phase 3
Overall status
Completed
Start date
May 2, 2017
Completion date
June 25, 2018
Enrollment
291 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

scabies